Sipa1 deficiency unleashes a host-immune mechanism eradicating chronic myelogenous leukemia-initiating cells.

about

Sipa1 deficiency unleashes a host-immune mechanism eradicating chronic myelogenous leukemia-initiating cells.

Item

http://www.wikidata.org/entity/Q50533003

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Sipa1 deficiency unleashes a h ...... ous leukemia-initiating cells.

@en

Sipa1 deficiency unleashes a h ...... ous leukemia-initiating cells.

@nl

type

Item

label

Sipa1 deficiency unleashes a h ...... ous leukemia-initiating cells.

@en

Sipa1 deficiency unleashes a h ...... ous leukemia-initiating cells.

@nl

prefLabel

Sipa1 deficiency unleashes a h ...... ous leukemia-initiating cells.

@en

Sipa1 deficiency unleashes a h ...... ous leukemia-initiating cells.

@nl

P1476

Sipa1 deficiency unleashes a h ...... ous leukemia-initiating cells.

@en

P2093

Hiroki Tanaka

http://www.w3.org/2001/XMLSchema#string

Kentaro Sumida

http://www.w3.org/2001/XMLSchema#string

Nagahiro Minato

http://www.w3.org/2001/XMLSchema#string

Ryusuke Yamamoto

http://www.w3.org/2001/XMLSchema#string

Satoshi Ikeda

http://www.w3.org/2001/XMLSchema#string

Yan Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of action and in vivo role of platelet-derived growth factor

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Bromodomain protein Brd4 binds to GTPase-activating SPA-1, modulating its activity and subcellular localization

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

GEFs and GAPs: critical elements in the control of small G proteins

Fibroblasts in cancer

P2888

s41467-018-03307-8

P304

914

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41467-018-03307-8

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29500416

http://www.w3.org/2001/XMLSchema#string

P932

5834470

http://www.w3.org/2001/XMLSchema#string